85 related articles for article (PubMed ID: 38650011)
1. Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib.
Hou CH; Chen WL; Lin CY
Cell Death Dis; 2024 May; 15(5):381. PubMed ID: 38816365
[TBL] [Abstract][Full Text] [Related]
2. [Knockdown mitochondrial transcription factor A (TFAM) inhibits autophagy, proliferation, invasion and migration in human cervical cancer and osteosarcoma cells].
Xu Y; Gao L; Yang J; Wang J; Jiang X; Yu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Apr; 40(4):311-318. PubMed ID: 38710515
[TBL] [Abstract][Full Text] [Related]
3. Silencing FUT4 Inhibits the Progression of Osteosarcoma through Activation of FOXO1.
Yang Y; Yan X; Chen Y; Liu J; Xue J; Sheng X; Qin J; Xue Q; Liu X
Curr Pharm Des; 2024; 30(6):440-447. PubMed ID: 38343056
[TBL] [Abstract][Full Text] [Related]
4. USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches.
Zhang Q; Zhu J; Xie J; Gu Y; Chen L
PeerJ; 2024; 12():e17397. PubMed ID: 38784391
[TBL] [Abstract][Full Text] [Related]
5. Sustained activation of the FGF1-MEK-ERK pathway inhibits proliferation, invasion and migration and enhances radiosensitivity in mouse angiosarcoma cells.
Miura T; Kado J; Ashisuke K; Masuzawa M; Nakayama F
J Radiat Res; 2024 May; 65(3):303-314. PubMed ID: 38637316
[TBL] [Abstract][Full Text] [Related]
6. High expression of DEC2 distinguishes chondroblastic osteosarcoma and promotes tumour growth by activating the VEGFC/VEGFR2 signalling pathway.
Tuerxun M; Zheng X; Xu J; Yang Q; Yuan T; Zhang C; Zhou S
J Cell Mol Med; 2024 Jun; 28(11):e18462. PubMed ID: 38847478
[TBL] [Abstract][Full Text] [Related]
7. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
Gao Y; Hou J; Fei X; Ren L; Lu R; Liu P; Liu S; Zhu C; Wang X; Pan Y
Cell Signal; 2024 May; 120():111227. PubMed ID: 38744388
[TBL] [Abstract][Full Text] [Related]
8. TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway.
Tian Y; Xin S; Wan Z; Dong H; Liu L; Fan Z; Li T; Peng F; Xiong Y; Han Y
Transl Oncol; 2024 Jul; 45():101978. PubMed ID: 38701650
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of RGS16 at Tyr168 promote HBeAg-mediated macrophage activation by ERK pathway to accelerate liver injury.
Tian M; Wu N; Xie X; Liu T; You Y; Ma S; Bian H; Cao H; Wang L; Liu C; Qi J
J Mol Med (Berl); 2024 Feb; 102(2):257-272. PubMed ID: 38141114
[TBL] [Abstract][Full Text] [Related]
10. Isoglutaminyl Cyclase Overexpression Enhances KYSE30 Cancer Cell Proliferation and Migration via the MAPK Signaling Pathway.
Chen X; Yu X; Cui Y; Du L; Zhou Q; Xiong W; Li C; Xu C; Wu H
J Proteome Res; 2024 May; 23(5):1859-1870. PubMed ID: 38655723
[TBL] [Abstract][Full Text] [Related]
11. KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2.
Zhong L; Dong Y; Liu S
Mol Carcinog; 2024 May; ():. PubMed ID: 38818892
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligase TRIM22 inhibits ovarian cancer malignancy via TCF4 degradation.
Tao T; Zhang Y; Guan C; Wang S; Liu X; Wang M
Mol Cancer Res; 2024 Jun; ():. PubMed ID: 38842601
[TBL] [Abstract][Full Text] [Related]
13. In vivo Targeting MEK and TNK2/SRC pathways in PTPN11 driven leukemia.
Chang BH; Thiel-Klare K; Tyner JW
bioRxiv; 2024 May; ():. PubMed ID: 38798550
[TBL] [Abstract][Full Text] [Related]
14. STIL facilitates the development and malignant progression of triple-negative breast cancer through activation of Fanconi anemia pathway via interacting with KLF16.
Wang M; Pan B; Hu Y; Gao J; Hou L; Yu Z; Li M; Zhao Z
Transl Oncol; 2024 May; 46():102010. PubMed ID: 38823260
[TBL] [Abstract][Full Text] [Related]
15. KAT7 serves as an oncogenic gene and regulates CCL3 expression via STAT1 signaling in osteosarcoma.
Yuan Q; Wu Y; Xue C; Zhao D; Wang H; Shen Y
Biochem Biophys Res Commun; 2024 May; 722():150156. PubMed ID: 38797155
[TBL] [Abstract][Full Text] [Related]
16. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circVRK1 suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating zinc finger protein ZNF652 expression via microRNA miR-337-3p.
Cheng C; Zhang H; Dai Z; Zheng J
Bioengineered; 2021 Dec; 12(1):5411-5427. PubMed ID: 34424826
[TBL] [Abstract][Full Text] [Related]
18. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.
Silva G; Aboussekhra A
Mol Carcinog; 2016 May; 55(5):525-36. PubMed ID: 25728247
[TBL] [Abstract][Full Text] [Related]
19. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
